InvestorsHub Logo

Maverick0408

01/06/22 8:23 AM

#432522 RE: Flexroy #432519

It’s super interesting! Will the Jan edition of NEJM Evidence also result in FDA finalizing their guidance document around the same time? This could also open the doors for NWBO to finally update US clinical trials website with new endpoints in the next few weeks?

Also, interesting is that Dr. Bosch is presenting on Jan 19. These series of events in Jan have the potential of strong and exciting catalysts we have all been waiting for!

newman2021

01/06/22 8:30 AM

#432524 RE: Flexroy #432519

Yes indeed; now these high impact publishers won't play hardball reviewing manuscripts such as ours that has progressive trial. Wish we get the regulatory approval ahead of publication which would be a slap on their face of these journals.

flipper44

01/06/22 8:34 AM

#432526 RE: Flexroy #432519

Yep.